Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Browse by Current Cardiff authors

[up] Up a level
Number of items: 15.

Beresford, Mark, Casbard, Angela ORCID: https://orcid.org/0000-0001-6241-3052, Hudson, Zoe, Carucci, Margherita, Ingarfield, Kate, Gee, Julia ORCID: https://orcid.org/0000-0001-6483-2015, Smith, Joanna ORCID: https://orcid.org/0000-0003-4234-6686, Kitson, Terri ORCID: https://orcid.org/0000-0001-6333-046X, Alchami, Fouad, Madden, Tracie-Ann ORCID: https://orcid.org/0000-0001-7880-7873, Hayward, Larrie, Hwang, David, Spensley, Saiqa, Waters, Simon, Wheatley, Duncan and Jones, Robert H. ORCID: https://orcid.org/0000-0003-3576-9496 2023. Fulvestrant plus vandetanib versus placebo for the treatment of patients with metastatic breast cancer resistant to aromatase inhibitor therapy (FURVA): a multicentre, Phase 2, randomised controlled trial. BJC Reports 1 (1) , 13. 10.1038/s44276-023-00016-8
filefile

Gbinigie, Oghenekome, Ogburn, Emma, Allen, Julie, Dorward, Jienchi, Dobson, Melissa, Madden, Tracie-Ann ORCID: https://orcid.org/0000-0001-7880-7873, Yu, Ly-Mee, Lowe, David M., Rahman, Najib, Petrou, Stavros, Richards, Duncan, Hood, Kerenza ORCID: https://orcid.org/0000-0002-5268-8631, Patel, Mahendra, Saville, Benjamin R., Marion, Joe, Holmes, Jane, Png, May Ee, Hayward, Gail, Lown, Mark, Harris, Victoria, Jani, Bhautesh, Hart, Nigel, Khoo, Saye, Rutter, Heather, Chalk, Jem, Standing, Joseph F., Breuer, Judith, Lavallee, Layla, Hadley, Elizabeth, Cureton, Lucy, Benysek, Magdalena, Andersson, Monique I., Francis, Nick ORCID: https://orcid.org/0000-0001-8939-7312, Thomas, Nicholas P. B., Evans, Philip, van Hecke, Oliver, Koshkouei, Mona, Coates, Maria, Barrett, Sarah, Bateman, Clare, Davies, Jennifer, Raymundo-Wood, Ivy, Ustianowski, Andrew, Nguyen-Van-Tam, Jonathan, Carson-Stevens, Andrew ORCID: https://orcid.org/0000-0002-7580-7699, Hobbs, Richard, Little, Paul and Butler, Christopher C. ORCID: https://orcid.org/0000-0002-0102-3453 2023. Platform adaptive trial of novel antivirals for early treatment of COVID-19 In the community (PANORAMIC): protocol for a randomised, controlled, open-label, adaptive platform trial of community novel antiviral treatment of COVID-19 in people at increased risk of more severe disease. BMJ Open 13 , e069176. 10.1136/bmjopen-2022-069176
file

Butler, Christopher C ORCID: https://orcid.org/0000-0002-0102-3453, Hobbs, F D Richard, Gbinigie, Oghenekome A, Rahman, Najib M, Hayward, Gail, Richards, Duncan B, Dorward, Jienchi, Lowe, David M, Standing, Joseph F, Breuer, Judith, Khoo, Saye, Petrou, Stavros, Hood, Kerenza ORCID: https://orcid.org/0000-0002-5268-8631, Nguyen-Van-Tam, Jonathan S, Patel, Mahendra G, Saville, Benjamin R, Marion, Joe, Ogburn, Emma, Allen, Julie, Rutter, Heather, Francis, Nick, Thomas, Nicholas P B, Evans, Philip, Dobson, Melissa, Madden, Tracie-Ann ORCID: https://orcid.org/0000-0001-7880-7873, Holmes, Jane, Harris, Victoria, Png, May Ee, Lown, Mark, van Hecke, Oliver, Detry, Michelle A, Saunders, Christina T, Fitzgerald, Mark, Berry, Nicholas S, Mwandigha, Lazaro, Galal, Ushma, Mort, Sam, Jani, Bhautesh D, Hart, Nigel D, Ahmed, Haroon ORCID: https://orcid.org/0000-0002-0634-8548, Butler, Daniel, McKenna, Micheal, Chalk, Jem, Lavallee, Layla, Hadley, Elizabeth, Cureton, Lucy, Benysek, Magdalena, Andersson, Monique, Coates, Maria, Barrett, Sarah, Bateman, Clare, Davies, Jennifer C, Raymundo-Wood, Ivy, Ustianowski, Andrew, Carson-Stevens, Andrew ORCID: https://orcid.org/0000-0002-7580-7699, Yu, Ly-Mee, Little, Paul, Agyeman, Akosua A, Ahmed, Tanveer, Allcock, Damien, Beltran-Martinez, Adrian, Benedict, Oluseye E, Bird, Nigel, Brennan, Laura, Brown, Julianne, Burns, Gerard, Butler, Mike, Cheng, Zelda, Danson, Ruth, de Kare-Silver, Nigel, Dhasmana, Devesh, Dickson, Jon, Engamba, Serge, Fisher, Stacey, Fox, Robin, Frost, Eve, Gaunt, Richard, Ghosh, Sarit, Gilkar, Ishtiaq, Goodman, Anna, Granier, Steve, Howell, Aleksandra, Hussain, Iqbal, Hutchinson, Simon, Imlach, Marie, Irving, Greg, Jacobsen, Nicholas, Kennard, James, Khan, Umar, Knox, Kyle, Krasucki, Christopher, Law, Tom, Lee, Rem, Lester, Nicola, Lewis, David, Lunn, James, Mackintosh, Claire I., Mathukia, Mehul, Moore, Patrick, Morton, Seb, Murphy, Daniel, Nally, Rhiannon, Ndukauba, Chinonso, Ogundapo, Olufunto, Okeke, Henry, Patel, Amit, Patel, Kavil, Penfold, Ruth, Poonian, Satveer, Popoola, Olajide, Pora, Alexander, Prasad, Vibhore, Prasad, Rishabh, Razzaq, Omair, Richardson, Scot, Royal, Simon, Safa, Afsana, Sehdev, Satash, Sevenoaks, Tamsin, Shah, Divya, Sheikh, Aadil, Short, Vanessa, Sidhu, Baljinder S, Singh, Ivor, Soni, Yusuf, Thalasselis, Chris, Wilson, Pete, Wingfield, David, Wong, Michael, Woodall, Maximillian N J, Wooding, Nick, Woods, Sharon, Yong, Joanna, Yongblah, Francis and Zafar, Azhar 2023. Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial. The Lancet 401 (10373) 10.1016/S0140-6736(22)02597-1
file

Jones, Rob, Crabb, Simon, Chester, John ORCID: https://orcid.org/0000-0002-7830-3840, Elliott, Tony, Huddart, Robert, Birtle, Alison, Evans, Linda, Lester, Jason, Jagdev, Satinder, Casbard, Angela ORCID: https://orcid.org/0000-0001-6241-3052, Huang, Chao, Madden, Tracie-Ann ORCID: https://orcid.org/0000-0001-7880-7873 and Griffiths, Gareth 2020. A randomised phase II trial of carboplatin and gemcitabine +/- vandetanib in first line treatment of advanced urothelial cell cancer patients not suitable to receive cisplatin. BJU International 126 (2) , pp. 292-299. 10.1111/bju.15096
file

Jones, Robert H. ORCID: https://orcid.org/0000-0003-3576-9496, Casbard, Angela ORCID: https://orcid.org/0000-0001-6241-3052, Carucci, Margherita, Cox, Catrin, Butler, Rachel, Alchami, Fouad, Madden, Tracie-Ann ORCID: https://orcid.org/0000-0001-7880-7873, Bale, Catherine, Bezecny, Pavel, Joffe, Johnathan, Moon, Sarah, Twelves, Chris, Venkitaraman, Ramachandran, Waters, Simon, Foxley, Andrew and Howell, Sacha J. 2020. Fulvestrant plus capivasertib versus placebo after relapse or progression on an aromatase inhibitor in metastatic, oestrogen receptor-positive breast cancer (FAKTION): a multicentre, randomised, controlled, phase 2 trial. Lancet Oncology 21 (3) , pp. 345-347. 10.1016/S1470-2045(19)30817-4
file

Hurt, Christopher N. ORCID: https://orcid.org/0000-0003-1206-8355, Jones, Sadie E. F., Madden, Tracie-Ann ORCID: https://orcid.org/0000-0001-7880-7873, Fiander, Alison, Nordin, Andrew J., Naik, Raj, Powell, Ned, Carucci, Margherita and Tristram, Amanda 2018. Recurrence of vulval intraepithelial neoplasia following treatment with cidofovir or imiquimod: results from a multi-centre, randomised, phase II trial (RT3VIN). BJOG: An International Journal of Obstetrics and Gynaecology 125 (9) , pp. 1171-1177. 10.1111/1471-0528.15124
file

Jones, Robert J., Crabb, S. J., Chester, John D. ORCID: https://orcid.org/0000-0002-7830-3840, Elliott, T., Huddart, R. A., Birtie, A. J., Evans, L., Lester, Jason Francis, Huang, Chao, Casbard, Angela ORCID: https://orcid.org/0000-0001-6241-3052, Madden, Tracie-Ann ORCID: https://orcid.org/0000-0001-7880-7873 and Griffiths, Gareth 2016. TOUCAN: A randomised phase II trial of carboplatin and gemcitabine plus /- vandetanib in first line treatment of advanced urothelial cell cancer in patients who are not suitable to receive cisplatin [Abstract]. American Journal of Clinical Oncology 34 (S25) , 448.

Tristram, Amanda, Hurt, Christopher N. ORCID: https://orcid.org/0000-0003-1206-8355, Madden, Tracie ORCID: https://orcid.org/0000-0001-7880-7873, Powell, Ned, Man, Stephen ORCID: https://orcid.org/0000-0001-9103-1686, Hibbitts, Sam, Dutton, Peter, Jones, Sadie, Nordin, Andrew J., Naik, Raj, Fiander, Alison and Griffiths, Gareth 2014. Activity, safety, and feasibility of cidofovir and imiquimod for treatment of vulval intraepithelial neoplasia (RT³VIN): a multicentre, open-label, randomised, phase 2 trial. Lancet Oncology 15 (12) , pp. 1361-1368. 10.1016/S1470-2045(14)70456-5
file

Hutcheson, Iain Robert, Knowlden, Janice Mary, Madden, Tracie-Ann ORCID: https://orcid.org/0000-0001-7880-7873, Barrow, Denise, Gee, Julia Margaret Wendy ORCID: https://orcid.org/0000-0001-6483-2015, Wakeling, A. E. and Nicholson, Robert Ian 2003. Oestrogen receptor-mediated modulation of the EGFR/MAPK pathway in tamoxifen-resistant MCF-7 cells. Breast Cancer Research and Treatment 81 (1) , pp. 81-93. 10.1023/A:1025484908380

Knowlden, Janice Mary, Hutcheson, Iain Robert, Jones, Helen E., Madden, Tracie-Ann ORCID: https://orcid.org/0000-0001-7880-7873, Gee, Julia Margaret Wendy ORCID: https://orcid.org/0000-0001-6483-2015, Harper, Maureen Elaine, Barrow, Denise, Wakeling, A. E. and Nicholson, Robert Ian 2003. Elevated levels of epidermal growth factor receptor/c-erbB2 heterodimers mediate an autocrine growth regulatory pathway in tamoxifen-resistant MCF-7 cells. Endocrinology 144 (3) , pp. 1032-1044. 10.1210/en.2002-220620

Nicholson, Robert Ian, Gee, Julia Margaret Wendy ORCID: https://orcid.org/0000-0001-6483-2015, Knowlden, Janice Mary, McClelland, Richard Andrew, Madden, Tracie-Ann ORCID: https://orcid.org/0000-0001-7880-7873, Barrow, Denise and Hutcheson, Iain Robert 2003. The biology of antihormone failure in breast cancer. Breast Cancer Research and Treatment 80 (S1) , pp. 29-34. 10.1023/A:1025467500433

Gee, Julia Margaret Wendy ORCID: https://orcid.org/0000-0001-6483-2015, Harper, Maureen Elaine, Hutcheson, Iain Robert, Madden, Tracie-Ann ORCID: https://orcid.org/0000-0001-7880-7873, Barrow, Denise, Knowlden, Janice Mary, McClelland, Richard Andrew, Jordan, Nicola Jane, Wakeling, A. E. and Nicholson, Robert Ian 2002. ZD1839 ('Iressa') improves the antitumour activity of tamoxifen ('Nolvadex') and ICI 182, 780 ('Faslodex') in antihormone responsive breast cancer [Abstract]. European Journal of Cancer 38 (S7) , S59. 10.1016/S0959-8049(02)80835-8

Nicholson, Robert Ian, Harper, Maureen Elaine, Hutcheson, Iain Robert, Madden, Tracie-Ann ORCID: https://orcid.org/0000-0001-7880-7873, Barrow, Denise, Knowlden, Janice Mary, Jordan, Nicola Jane, Wakeling, A. E. and Gee, Julia Margaret Wendy ORCID: https://orcid.org/0000-0001-6483-2015 2001. ZD1839 (Iressa) improves the antitumor activity of tamoxifen (Nolvadex) in antihormone-responsive breast cancer cells [Abstract]. Clinical Cancer Research 7 (S) , 3766S.

McClelland, Richard Andrew, Barrow, Denise, Madden, Tracie-Ann ORCID: https://orcid.org/0000-0001-7880-7873, Dutkowski, Carol Mary, Pamment, Joanna Susan, Knowlden, Janice Mary, Gee, Julia Margaret Wendy ORCID: https://orcid.org/0000-0001-6483-2015 and Nicholson, Robert Ian 2001. Enhanced epidermal growth factor receptor signaling in MCF7 breast cancer cells after long-term culture in the presence of the pure antiestrogen ICI 182,780 (Faslodex). Endocrinology 142 (7) , pp. 2776-2788. 10.1210/en.142.7.2776

Madden, Tracie-Ann ORCID: https://orcid.org/0000-0001-7880-7873, Barrow, Denise, McClelland, Richard Andrew, Gee, Julia Margaret Wendy ORCID: https://orcid.org/0000-0001-6483-2015 and Nicholson, Robert Ian 2000. Modulation of oestrogen action by receptor gene inhibition. European Journal of Cancer 36 (S4) , pp. 34-35. 10.1016/S0959-8049(00)00216-1

This list was generated on Thu Feb 20 07:00:11 2025 GMT.


Maintained by Cardiff University Information Services